AstraZenca Pharma India

AstraZenca Pharma India

ASTRAZEN

 ₹ 5,708.70
 ₹ 32.10
0.56%

AstraZenca Pharma India  
Market Sentiment

TimelineReturnsVolume
Daily0.57%5,153
Weekly-0.87%36,116
Monthly8.02%3,71,484

AstraZenca Pharma India  
Performance

TimelineDailyWeeklyMonthly
ASTRAZEN0.57%-0.87%8.02%
Index-3.57%-1.42%-1.14%
Peer Avg.0.24%1.73%4.77%
*Avg of index constituents

AstraZenca Pharma India  
Fundamentals

TimelinePEPBEV/EBIDTAROEROCEDiv. Yield
ASTRAZEN103.7112.5458.8912.7817.360.28
Index36.206.7717.2517.8919.691.20
Peer Avg.35.313.9512.5516.537.422.36
*Avg of index constituents

AstraZenca Pharma India  
Key Metrics

MetricsSales GrowthProfit GrowthROEROCE
FY '21-22-0.98%-33.98%12.7817.36
FY '20-21-2.19%29.21%22.8331.24
FY '19-2014.21%32.62%21.8334.61

AstraZenca Pharma India  
Shareholding Pattern

PromotersFIIDIIPublicOthers
Promoters : 75%
FII : 2.38%
DII : 1.19%
Public : 21.43%
Others : 0%

AstraZenca Pharma India  
Profit & Loss

MetricsSalesExpenditureEBITDAPAT
FY '21-22805.60719.42100.9461.60
FY '20-21813.56678.09148.3193.30
FY '19-20831.81711.11133.6972.21
All values are in crores

AstraZenca Pharma India  
Peer Comparison

MetricsSalesExpenditureEBITDAPAT
ASTRAZEN805.60719.42100.9461.60
TEJASNET549.87630.89-37.75-63.22
GODREJAGRO7,244.946,667.83670.30364.57
All values are in crores

AstraZenca Pharma India  
Similar Stocks

Cipla

Cipla

CIPLA

 ₹ 1,485.95
- ₹ 3.20
-0.21%
Dr. Reddy's Laboratories
 ₹ 5,875.75
- ₹ 21.95
-0.37%
Lupin

Lupin

LUPIN

 ₹ 1,627.45
- ₹ 5.20
-0.31%
Torrent Pharmaceuticals
 ₹ 2,657.00
- ₹ 35.90
-1.33%
Glaxosmithkline Pharmaceuticals
 ₹ 2,474.00
 ₹ 0.45
0.01%

AstraZenca Pharma India Share Price

AstraZeneca Pharma India Limited is an Indian biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolic; oncology and respiratory diseases. The company operates through the healthcare segment. The company manufactures, markets and distributes pharmaceuticals and provides clinical research services to a foreign group company. Its therapeutic offering in the CVRM business includes Forxiga (Dapagliflozin) in heart failure and chronic kidney disease. Its approvals in the oncology business include Imfinz (Durvalumab) for the treatment of bile duct carcinoma and Lynparza (Olaparib) for early breast cancer. The company has a range of oral diabetes medications that fall into two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The company's DPP4 offering consists of the Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metform) brands.

AstraZenca Pharma India FAQs

How to Buy AstraZenca Pharma India Share?

virtual
To purchase AstraZenca Pharma India shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for AstraZenca Pharma India (ticker symbol: astrazen) on the trading platform provided by your broker and purchase the shares.

What's AstraZenca Pharma India share price today?

virtual
The stock price of AstraZenca Pharma India as of 24 May 2024 is ₹5,708.70

What is the Market Cap of AstraZenca Pharma India?

virtual
Market capitalisation represents the total market value of a company's outstanding shares. As of 24 May 2024, AstraZenca Pharma India (ticker symbol: astrazen) has a market capitalisation of approximately ₹87,87,62,50,000.00

What is the PE and PB ratio of AstraZenca Pharma India?

virtual
AstraZenca Pharma India Ltd's price-to-book ratio as of 24 May 2024 is 12.540485, reflecting the market's valuation compared to its asset value. As of 24 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 103.71144, indicating the market values the company at around ₹103.71 for every ₹1 of earnings

What is the 52 Week High and Low of AstraZenca Pharma India Share?

virtual
AstraZenca Pharma India Ltd (astrazen) hit its 52-week high at ₹7,220.95, and its 52-week low at { ₹3,165.15}.
Want to learn and earn in Stocks?